People with a common personality trait practiced by as many as one in five Americans may see fewer lasting results from GLP-1 agonists like Ozempic and Wegovy, a study from Japan suggests.
Emotional eaters may see fewer results from blockbuster weight loss drugs like Ozempic, a study suggests.
Researchers in Japan tracked nearly 100 people with type 2 diabetes over the course of their first year taking GLP-1 agonists like Ozempic, Wego... [4920 chars]